Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet Co. (NASDAQ:PODD – Get Rating)’s stock price was down 3% during mid-day trading on Tuesday . The stock traded as low as $287.78 and last traded at $287.83. Approximately 140,424 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 701,642 shares. The stock had previously closed at […]
Insulet Co. (NASDAQ:PODD – Get Rating) SVP Dan Manea sold 175 shares of the firm’s stock in a transaction dated Tuesday, June 20th. The shares were sold at an average price of $290.00, for a total transaction of $50,750.00. Following the completion of the transaction, the senior vice president now directly owns 4,522 shares in […]
Insulet Co. (NASDAQ:PODD – Get Rating) SVP Dan Manea sold 175 shares of Insulet stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $290.00, for a total transaction of $50,750.00. Following the completion of the sale, the senior vice president now directly owns 4,522 shares of the […]
Insulet (NASDAQ:PODD – Get Rating) and Femasys (NASDAQ:FEMY – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of current recommendations for Insulet and […]
Fred Alger Management LLC cut its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 10.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 565,632 shares of the medical instruments supplier’s stock after selling 66,419 shares during the quarter. Insulet comprises about 0.9% […]